ARTICLES

Cancer Research

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC) Read more...

Concurrent chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy (sequential approach) in the management of head and neck cancer Read more...

Castrate-resistant Prostate Cancer-Recent Advances in Therapy and Future Perspectives Read more...

Central nervous system toxicities of chemotherapeutic agents Read more...

A randomized, placebo-controlled, multicenter, biomarker-selected, phase 2 study of apricoxib in combination with erlotinib in patients with advanced non-small-cell lung cancer Read more...

Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation Read more...

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors Read more...

Concurrent radiotherapy with carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma Read more...